Skip to content

Cyera

AI-native data security platform that discovers and classifies sensitive data across cloud, SaaS and on-prem and extends into data loss prevention and AI.

Visit Website ↗ + Add to Compare Claim This Company
73/100Meaningful Innovator

Overview

Cyera scans cloud accounts, data stores and SaaS applications to map where sensitive data lives, classify it, and flag exposure. It combines data security posture management with data loss prevention and identity context in one platform.

The company has extended into AI environments with its AI Guardian product, aiming to control what data AI systems and agents can reach.

Its pitch is that classification quality and context reduce the manual tuning that has plagued legacy DLP, though it is still maturing against established data protection incumbents.

Innovation Matrix Assessment

Innovation Velocity 8/10

Rapid product expansion from DSPM into DLP and AI data controls within a few years.

Operational Value 7/10

Automated discovery and classification addresses a long-standing blind spot for CISOs.

Market Momentum 8/10

Raised $600M at a $12B valuation in June 2026 per SecurityWeek and Globes, with more than $2.3B total funding.

Category Disruption 7/10

Converging DSPM, DLP and identity is a genuine category shift, though still being proven.

Real-World Efficacy 6/10

Funding is well evidenced, but independent efficacy data was not found; effectiveness claims are mostly vendor-stated.

Enduring Relevance 8/10

Data governance for AI and agents makes the problem more relevant over time.

Why CISOs Should Care

Shows where sensitive data is and who or what can reach it, which underpins AI adoption and compliance decisions.

What Makes It Different

Positions classification and context as the base for DLP, replacing pattern-matching rules.

The Matrix Verdict

73/100 — MEANINGFUL INNOVATOR

Cyera scores 73/100, placing it in the Meaningful Innovator tier. The score reflects the strengths and limits described in the dimension rationales, with higher marks only where independently reported evidence supports them.

Editorial Note: Claims vs. Verified Findings

Valuation and funding are press-reported; one outlet reported a differing round size and a later extension was unconfirmed. Product effectiveness is vendor-stated.

Sources